High activity rhenium-186 hydroxyethylidene diphosphonate (HEDP) with autologous peripheral blood stem cell (PBSC) transplant: A novel treatment strategy in hormone refractory prostate cancer metastatic to bone.

Joe O'Sullivan; A.R. Norman; V.R. McCready; G. Flux; G. Cook; B. Johnson; J. Treleaven; D.P. Dearnaley

High activity rhenium-186 hydroxyethylidene diphosphonate (HEDP) with autologous peripheral blood stem cell (PBSC) transplant: A novel treatment strategy in hormone refractory prostate cancer metastatic to bone.

Joe O'Sullivan, A.R. Norman, V.R. McCready, G. Flux, G. Cook, B. Johnson, J. Treleaven, D.P. Dearnaley

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	397S-397S
Journal	Journal of Clinical Oncology
Volume	22
Publication status	Published - 2004

Cite this

O'Sullivan, J., Norman, A. R., McCready, V. R., Flux, G., Cook, G., Johnson, B., Treleaven, J., & Dearnaley, D. P. (2004). High activity rhenium-186 hydroxyethylidene diphosphonate (HEDP) with autologous peripheral blood stem cell (PBSC) transplant: A novel treatment strategy in hormone refractory prostate cancer metastatic to bone. Journal of Clinical Oncology, 22, 397S-397S.

O'Sullivan, Joe ; Norman, A.R. ; McCready, V.R. ; Flux, G. ; Cook, G. ; Johnson, B. ; Treleaven, J. ; Dearnaley, D.P. / High activity rhenium-186 hydroxyethylidene diphosphonate (HEDP) with autologous peripheral blood stem cell (PBSC) transplant: A novel treatment strategy in hormone refractory prostate cancer metastatic to bone. In: Journal of Clinical Oncology. 2004 ; Vol. 22. pp. 397S-397S.

@article{d629981919b842549bd1cc929cddeb6b,

title = "High activity rhenium-186 hydroxyethylidene diphosphonate (HEDP) with autologous peripheral blood stem cell (PBSC) transplant: A novel treatment strategy in hormone refractory prostate cancer metastatic to bone.",

author = "Joe O'Sullivan and A.R. Norman and V.R. McCready and G. Flux and G. Cook and B. Johnson and J. Treleaven and D.P. Dearnaley",

year = "2004",

language = "English",

volume = "22",

pages = "397S--397S",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

}

O'Sullivan, J, Norman, AR, McCready, VR, Flux, G, Cook, G, Johnson, B, Treleaven, J & Dearnaley, DP 2004, 'High activity rhenium-186 hydroxyethylidene diphosphonate (HEDP) with autologous peripheral blood stem cell (PBSC) transplant: A novel treatment strategy in hormone refractory prostate cancer metastatic to bone.', Journal of Clinical Oncology, vol. 22, pp. 397S-397S.

High activity rhenium-186 hydroxyethylidene diphosphonate (HEDP) with autologous peripheral blood stem cell (PBSC) transplant: A novel treatment strategy in hormone refractory prostate cancer metastatic to bone. / O'Sullivan, Joe; Norman, A.R.; McCready, V.R.; Flux, G.; Cook, G.; Johnson, B.; Treleaven, J.; Dearnaley, D.P.

In: Journal of Clinical Oncology, Vol. 22, 2004, p. 397S-397S.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - High activity rhenium-186 hydroxyethylidene diphosphonate (HEDP) with autologous peripheral blood stem cell (PBSC) transplant: A novel treatment strategy in hormone refractory prostate cancer metastatic to bone.

AU - O'Sullivan, Joe

AU - Norman, A.R.

AU - McCready, V.R.

AU - Flux, G.

AU - Cook, G.

AU - Johnson, B.

AU - Treleaven, J.

AU - Dearnaley, D.P.

PY - 2004

Y1 - 2004

M3 - Article

VL - 22

SP - 397S-397S

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

ER -